Neurobo Pharmaceuticals Inc (NASDAQ:NRBO)
| 0.8097 Delayed Data As of Jan 27 |  +0.008 / +1.00%Today’s Change | 0.55 Today|||52-Week Range 63.85 | +12.85% Year-to-Date |
Latest NRBO News | Press Releases
No recent news for Neurobo Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.80 |
| Today’s open | 0.80 |
| Day’s range | 0.78 - 0.81 |
| Volume | 15,920 |
| Average volume (3 months) | 2,907,512 |
| Market cap | $15.4M |
Data as of 3:59pm ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | +63.91% |
| Earnings growth (this year) | +41.58% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.05 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TTNPTitan Pharmaceutical... | 0.00 | 0.00% |
| ATHEAlterity Therapeutic... | 0.00 | 0.00% |
| ACRXAcelRx Pharmaceutica... | -0.02 | -1.01% |
| PULMPulmatrix Inc | 0.00 | 0.00% |
Data as of 3:59pm ET, 01/27/2023
Financials
| Last reporting date | April 1, 2022 |
| EPS forecast (this quarter) | -$4.50 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$15.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
